Preliminary study of the insulin growth factor binding protein-3 (IGFBP3) level in Iraqi women with breast cancer

12Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Here, a high sensitive method for biomarker identification according to nanostructure, using enzyme-linked immunosorbent assays (ELISAs), called Nano-ELISA, was presented. Different shapes of gold nanostructures (star and sphere; GNSs and GNPs) with a particle size of 40nm for sphere particles were altered with a monoclonal antibody (Ab) as a detector Ab. To amplify the optical signal, gold nanostructures were employed as carriers of the signaling specific antibody against insulin growth factor binding protein- 3 (IGFBP-3). The substrate was catalytically oxidized by the Horseradish Peroxidase (HRP) conjugated gold nanostructure, and HRP also enhanced the optical signals, reflecting the amount of the targeting IGFBP-3. In comparison to the classical ELISA procedure, this assay using gold nanostructure as an enhancer, have higher sensitivity and shorter testing time, in the spectrum between 0.05ng/mL and 30ng/mL. Gold nanostar based ELISA assay (GNS-based ELISA) have lower LOD, signal amplification potency, and higher specificity and sensitivity, compared to gold nanoparticles based ELISA (GNP- based ELISA) assay.

Author supplied keywords

Cite

CITATION STYLE

APA

Faris, R. A., Mahdi, Z. F., & Al-Layla, A. M. T. (2021). Preliminary study of the insulin growth factor binding protein-3 (IGFBP3) level in Iraqi women with breast cancer. In AIP Conference Proceedings (Vol. 2372). American Institute of Physics Inc. https://doi.org/10.1063/5.0065368

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free